Tag Archives: pfizer

Measures to curb ‘Inversions’ announced: US Treasury

United States Department of Treasury and Internal Revenue Service has announced measures to curb ‘Inversions’ by US corporations. https://goo.gl/hsGD0P

Posted in Banking Law, Company Law, Contract Law, FDI, General Law, Income Tax Law, International Law, Notifications/Publications/Circulars, Securities Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Cipla not infringing Pfizer patent for drug Tarceva: DHC

In a big relief to pharmaceutical company Cipla Ltd. (“Cipla”), the Delhi High Court ruled that Cipla did not infringe OSI/Pfizer (“Pfizer”) Indian patent for their drug ‘Erlotinib’ (trade name ‘Tarceva’) by manufacture, marketing and sale of their drug ‘Erlocip’, … Continue reading

Posted in Intellectual Property Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment